Raden Suhartono

Raden Suhartono

Auto-generated profile, based on publicly available information

Raden Suhartono

Division of Vascular and Endovascular Surgery, Department of Surgery, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2021 in International Journal of Surgery
Verified
Journal Article
Open access
MMM. Akmal Marethania
M. Akmal Marethania
RDR. Pabittei Dara
R. Pabittei Dara
TPTossapol Prapassaro
Tossapol Prapassaro
RSRaden Suhartono
Raden Suhartono
FMFrans Moll
Frans Moll
JHJoost A. van Herwaarden van Herwaarden
Joost A. van Herwaarden van Herwaarden
Objective: To study the mid- and long-term outcomes of type II endoleak treatment after EVAR and the technical aspects of different techniques to exclude endoleaks which different embolic agents. Methods: A systematic review was performed using the approach recommended by the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for meta-analyses of interventional studies. The comprehensive search was conducted using the following database: MEDLINE, EMBASE, and the Cochrane Library. Patient characteristic, intervention approaches, embolic agents, and results at mid and long term follow up were studied. Results: A total of 6 studies corresponding to a total of 141 patients fulfilled the inclusion criteria with a mean age of 73–78.6 years and a mean duration of follow up varying from 25 to 42 months. There were different techniques for embolization used (translumbar, transarterial, and transcaval approach) with various types of embolic agents. In all studies, the indication for embolization of the type II endoleaks was sac enlargement of more than 5 mm. A wide range of technical success rate was reported regardless of the intervention strategy being used (17,6%–100%). The overall technical success rate of all studies was 62%. Conclusion: This systematic review shows that there is a wide variety of techniques to exclude a persistent type II endoleak. Different kinds of embolic agents have be used. Due to a lack of peer reviewed data on longterm follow-up, it was not possible to come to recommendations what treatment would be the best for a durable exclusion of a persistent type II endoleak after an initially successful EVAR. There remains an urgent need for proper executed studies, either randomized or with close observation in relation to longer follow-up.

20 September 2022 in Life
Verified
Journal Article
Open access
PDF file
AMAkhmadu Muradi
Akhmadu Muradi
CJChyntia Olivia Maurine Jasirwan
Chyntia Olivia Maurine Jasirwan
CSCharley Simanjuntak
Charley Simanjuntak
DPDedy Pratama
Dedy Pratama
RSRaden Suhartono
Raden Suhartono
AKAria Kekalih
Aria Kekalih
Diabetes mellitus (DM) is a significant risk factor for peripheral arterial disease (PAD). PAD affects 20% of DM patients over 40 and has increased by 29% in the last 50 years. The gut microbiota produces short-chain fatty acids (SCFAs) that affect atherosclerosis. SCFA inhibits inflammation, which contributes to atherosclerosis. This study tried to link feces SCFA levels to atherosclerosis in people with diabetes with peripheral arterial disease (PAD). The study included 53 people with diabetes and PAD: gas chromatography-mass spectrometry measured acetate, butyrate, and propionate levels in feces samples (GC-MS). There was a positive correlation between random blood glucose (RBG) levels, peak systolic velocity (PSV), volume flow (VF), plaque, relative and absolute acetate, relative valerate, butyrate, and propionate. This supports the idea that elevated SCFA levels in type 2 diabetic (T2D) patients reduce adipose tissue inflammation and cholesterol metabolism, contributing to atherosclerosis pathogenesis. We conclude that increased fecal SCFA excretion is linked to cardiovascular disease. To determine the causal effect correlation of the SCFA with clinical and laboratory parameters for PAD in DM patients, compare the SCFA in plasma and feces, and account for confounding variables, a specific method with larger sample sizes and more extended follow-up periods is required.

20 November 2023 in Surgery Open Science
Verified
Journal Article
Open access
HEHendri
Hendri
RSRaden Suhartono
Raden Suhartono
AKAria Kekalih
Aria Kekalih
JAJanuar Rizky Adriani
Januar Rizky Adriani
MFMuhammad Faruk
Muhammad Faruk
Revascularization is important for the healing of diabetic foot ulcers with peripheral arterial disease because it aids in the restoration of the perfusion function of the leg tissues and can reduce the risk of cardiovascular complications. However, no Indonesian studies have been identified that exclusively discuss the effectiveness of revascularization for patients with this condition. This study aimed to compare the healing rates of diabetic foot ulcers with peripheral arterial disease in patients who received or did not receive revascularization. This cohort study included diabetic foot ulcer patients with peripheral arterial disease undergoing treatment at our institution who received or did not receive revascularization based on the wound, ischemia, and foot infection (WIfI) score criteria. Wound healing was considered complete re-epithelialization within six months of the procedure or consistent epithelialization for four consecutive weeks. Patients who required amputation within six months of observation were deemed to have failed therapy. Each group contained 23 patients. The revascularization group exhibited a healing rate of 78.3 % (18 patients), while the non-revascularization patients had a rate of 26.1 % (6 patients). The wounds of revascularized patients were 14.944 (1.102–202.692) times more likely to heal than those without revascularization (p < 0.01). WIfI stage 2–3 patients showed an 11.926 (1.438–98.883) times increase in the likelihood of wound healing compared to stage 4 WIfI patients. The wound healing rate was higher for revascularized patients than for non-revascularized patients, and the severity of the wound based on WIfI score affected patient wound healing.

17 August 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
RSR. Suhartono
R. Suhartono
SUSuhendro
Suhendro
HRHarrina Erlianti Rahardjo
Harrina Erlianti Rahardjo
AHAlida Roswita Harahap
Alida Roswita Harahap
CMChaidir Arif Mochtar
Chaidir Arif Mochtar
RRRaflis Rustam
Raflis Rustam
Background: Chronic kidney disease (CKD) and end-stage kidney disease (ESKD) cause major morbidity and mortality in 10% of the global population with CKD. The most common renal replacement therapy is hemodialysis with arteriovenous fistula (AVF) access. AVF often undergoes maturation failure due to feeding artery and draining vein inadequacy. Mechanical dilatation, such as primary balloon angioplasty (PBA), can overcome AVF maturation failure. The volume flow (VF) and diameter of the draining veins in AVF patients must be known to evaluate the effect of PBA on AVF maturation. This study aims to analyze the impact of PBA on VF and draining vein diameter in ESKD patients undergoing AVF surgery. Methods: A retrospective cohort clinical trial was conducted at our institution. A total of 75 participants had AVF with an arterial diameter >1.5 mm or vein diameter at the AVF creation site of 2-4 mm. The subjects were divided into 2 groups: the intervention group undergoing PBA (n = 36) and the control group, without PBA (n = 39). PBA was performed using a Mustang ballon (3-6 mm, Medtronic). Follow-ups were conducted at 1 week, 2 weeks, and 6 weeks after AVF creation. Results: Based on the data, the diameter and VF of the draining veins were significantly larger in the intervention group than in the control group (p < 0.001). Furthermore, we found significant differences in the mean diameter and VF of the draining veins between the control and intervention groups at all stages of examination, from preoperatively to 6 weeks postoperatively (p < 0.001). The strength of the analysis was more than 80%. Conclusion: PBA can increase the diameter and VF of the draining veins in patients with AVF.

14 April 2025 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
RSRaden Suhartono
Raden Suhartono
IRIvan Rinaldi
Ivan Rinaldi
DSDhanasari Vidiawati Sanyoto
Dhanasari Vidiawati Sanyoto
JAJanuar Rizky Adriani
Januar Rizky Adriani
MFMuhammad Faruk
Muhammad Faruk

30 April 2019 in The New Ropanasuri Journal of Surgery
Verified
Journal Article
Open access
PDF file
DSDivision of Vascular Surgery
Division of Vascular Surgery
RSRaden Suhartono
Raden Suhartono
CSCaroline Supit
Caroline Supit
Duration and frequency of catheterization in central vein stenosis: A case control study